Lisa A S Walker
Overview
Explore the profile of Lisa A S Walker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamwi M, Thebault S, Melkus G, Auriat A, Pham A, Carrington A, et al.
Mult Scler Relat Disord
. 2024 Nov;
80:105066.
PMID: 39491411
Purpose: We sought to determine if structural network parameters add to traditional markers of MS treatment response following immunoablation and autologous haemopoietic stem cell transplantation (IAHSCT). The post-IAHSCT paradigm afforded...
2.
Chaves A, Edwards T, Awadia Z, Morin V, Walker L, Reed J, et al.
Mult Scler Relat Disord
. 2024 Sep;
91:105854.
PMID: 39245024
Introduction: Physiological fitness, encompassing cardiorespiratory fitness (CRF) and body composition, are important markers of overall health, functional capacity, and quality of life in general and clinical populations. Characterizing fitness is...
3.
Pumphrey J, Ramani S, Islam T, Berard J, Seegobin M, Lymer J, et al.
Mult Scler Relat Disord
. 2024 Apr;
86:105603.
PMID: 38583368
Background: Multiple sclerosis (MS) negatively impacts cognition and has been associated with deficits in social cognition, including emotion recognition. There is a lack of research examining emotion recognition from multiple...
4.
Fabiano N, Dholakia S, Walker L, Smith A
BMJ Case Rep
. 2024 Mar;
17(3).
PMID: 38453220
Dimenhydrinate is an over-the-counter antihistaminergic medication with anticholinergic properties used to treat nausea or motion sickness worldwide. There is a well-established correlation between the use of anticholinergic medications and dementia,...
5.
Walker L, Berard J, Islam T, Pilutti L, Morrow S, Finlayson M
Front Rehabil Sci
. 2022 Dec;
3:999266.
PMID: 36518350
Background: Up to 90% of people with multiple sclerosis (PwMS) subjectively report fatigue as one of their worst symptoms. Fatigability is an objectively measured component of fatigue. Cognitive fatigability (CF)...
6.
MacAdam E, Berard J, Walker L
Can J Neurol Sci
. 2022 Oct;
50(6):870-875.
PMID: 36280897
Background: Slowed processing speed impacts employment status in people with multiple sclerosis (PwMS). Studies on the Multiple Sclerosis Functional Composite (MSFC), which includes the Paced Auditory Serial Addition Test (PASAT),...
7.
Berrigan L, LeFevre J, Rees L, Berard J, Francis A, Freedman M, et al.
Mult Scler Relat Disord
. 2022 Oct;
68:104229.
PMID: 36279599
Background: Slowed processing speed is the most frequently reported cognitive deficit for people with multiple sclerosis (MS). However, measures used to assess processing speed may also recruit other cognitive abilities....
8.
Berard J, Walker L
Mult Scler Relat Disord
. 2022 May;
63:103865.
PMID: 35580469
Background: Canada is amongst the countries with the highest rates of multiple sclerosis (MS). Given cognitive deficits can occur in up to 70% of individuals with MS, there is a...
9.
Berard J, Freedman M, Marrie R, Marriott J, Atkins H, Szwajcer D, et al.
Mult Scler Relat Disord
. 2022 Apr;
61:103779.
PMID: 35367874
Background: Mesenchymal stem cell (MSC) therapies are being evaluated in multiple sclerosis (MS) for possible neural repair. To date, the potential benefits on cognition have received little attention. The objective...
10.
Walker C, Berard J, Walker L
Front Neurosci
. 2021 Dec;
15:730817.
PMID: 34867152
Cognitive fatigability is an objective performance decrement that occurs over time during a task requiring sustained cognitive effort. Although cognitive fatigability is a common and debilitating symptom in multiple sclerosis...